# Insulin, Neurogenetics and Memory in Alzheimer's Disease

> **NCT00018382** · PHASE2 · COMPLETED · sponsor: **US Department of Veterans Affairs**

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** rosiglitazone

## Key facts

- **NCT ID:** NCT00018382
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** 2003-03
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00018382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00018382, "Insulin, Neurogenetics and Memory in Alzheimer's Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00018382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*